Chinese vaccine maker aims to increase global markets

Source:

ce.cn

Key Topics in this News Article:

Biotech China Chinese Covid-19 Economy Pandemic Pharmaceutical Technology Vaccine

News Snapshot:

China National Biotech Group, a subsidiary of pharmaceutical giant Sinopharm, has made unprecedented forays into the global vaccine market amid the COVID-19 pandemic, said Zhang Yuntao, vice-president of the company.

News Timeline | Services | Contact | About | Privacy

© 2024 ChinaPulse.com. Individual news stories are copyright their respective sources. Computer algorithms generally select what is shown on ChinaPulse.com. The algorithms determine which stories, images, and videos show, and in what order. A service of Asia Media Network.